Results 181 to 190 of about 931,651 (296)

Biographical Feature: Thomas F. Smith, Ph.D. [PDF]

, 2017
Munson, Erik
core   +1 more source

Correction: Novel anti-CEA affibody for rapid tumor-targeting and molecular imaging diagnosis in mice bearing gastrointestinal cancer cell lines. [PDF]

Front Microbiol
Shao H, Lv K, Wang P, Jin J, Cai Y, Chen J, Kamara S, Zhu S, Zhu G, Zhang L.   +9 more
europepmc   +1 more source

Pathogenic PF4/Polyanion ELISA‐Negative Antibodies in HIT

American Journal of Hematology, EarlyView.
ABSTRACT Background Platelet factor 4‐polyanion enzyme‐linked immunosorbent assays (ELISAs) are considered highly sensitive for diagnosing heparin‐induced thrombocytopenia (HIT), such that current practice guidelines recommend use of ELISA‐negative results to exclude HIT.
Adam J. Kanack, Noah P. Splinter, Emily E. Mauch, Leben Tefera, Morayma Reyes Gil, Sakshi Jasra, Andrew Goodwin, Kristi J. Smock, Hadiyah Ahmad, Aneel Ashrani, Nathaniel L. Robinson, Ana I. Casanegra, Curtis G. Jones, Shannon M. Pechauer, Erin Yttre, Richard H. Aster, Mindy C. Kohlhagen, Rachel R. Leger, Gretchen Johns, David L. Murray, Lu Zhou, Demin Wang, Renren Wen, Dong Chen, Rajiv K. Pruthi, Anand Padmanabhan   +25 more
wiley   +1 more source

Clinical Characteristics, Management and Outcomes of Nonintensive Care Unit Candidemia: Subanalysis of the ECMM <i>Candida</i> III Multinational European Observational Cohort Study. [PDF]

Open Forum Infect Dis
Wolfgruber S, Garcia-Vidal C, Sedik S, Salmanton-García J, Arikan-Akdagli S, Gangneux JP, Rautemaa-Richardson R, Arsić-Arsenijević V, Martín-Pérez S, Dávila-Valls J, Erben N, Akalin EH, Drgona L, Lass-Flörl C, García-Rodríguez J, Bicanic T, Hammarström H, Hamal P, Steinmann J, Meijer EFJ, Khanna N, Desoubeaux G, Longval T, Sili U, Trauth J, Bassetti M, White PL, Aujayeb A, Matos T, Akyol D, Danion F, Lagrou K, Rogers B, Ruiz M, Siváková A, Mikulska M, Samarkos M, Blennow O, Lockhart DEA, Denis B, Willinger B, van Dijk K, Scharmann U, Goodman AL, van Praet J, Narayanan M, Toscano C, Loughlin L, de Jonge NA, Ruiz-Gaitan A, Lanternier F, Prattes J, Roilides E, Talento AF, Barac A, Egger M, Arendrup MC, Koehler P, Cornely OA, Hoenigl M, ECMM Candida III study group .   +60 more
europepmc   +1 more source

Real‐World Outcomes of Mycosis Fungoides and Site‐Specific Nodal Involvement: A Registry‐Based Study of 25 467 Patients

American Journal of Hematology, EarlyView.
ABSTRACT Mycosis fungoides (MF) is a rare extranodal T‐cell lymphoma with primary cutaneous involvement. While it is the most common primary skin lymphoma, large‐scale real‐world data defining survival benchmarks and the prognostic significance of specific nodal sites remain limited.
Charalampos Filippatos, Alexandros Briasoulis, Evangelos Terpos, Despina Fotiou, Maria Gavriatopoulou   +4 more
wiley   +1 more source

Impact of Total Laboratory Automation on Urine Culture Turnaround Time: A Comparative Study Between Manual Workflow and WASPLab™. [PDF]

Diagnostics (Basel)
Khalid F, Alzahrani AJ, Mohammed H, Gamma AKA, Hassan ME, Poulose C, ElSheikh A, Sumaily K, Alharbi AA, Aldrous NF, Alsaadan M, Alnamnakani M, Khojah OT.   +12 more
europepmc   +1 more source

Compound Heterozygosity for Hemoglobin S and Hemoglobin LuLu Island

American Journal of Hematology, EarlyView.
Dana Lewis, Thomas Lofaro, Laura Fraser, Sheana Wijemanne, Barbara J. Bain   +4 more
wiley   +1 more source

Genomic comparison of methicillin-resistant <i>Staphylococcus aureus</i> CC398 isolates from livestock, meat and humans in the Netherlands. [PDF]

Front Microbiol
van Duijkeren E, Dierikx CM, Brouwer MSM, Veldman KT, Wullings B, Rapallini M, Wit B, Cuperus T, Hengeveld PD, van Hoek AHAM, de Haan A, Witteveen S, Hendrickx APA.   +12 more
europepmc   +1 more source

Real‐World Outcomes of FLAG‐Ida Regimen in 1079 Adult Patients With First Relapsed/Refractory AML: A PETHEMA Study

American Journal of Hematology, EarlyView.
ABSTRACT In a large multicenter real‐world cohort, we aimed to evaluate outcomes of FLAG‐Ida salvage therapy for relapsed/refractory (R/R) acute myeloid leukemia (AML) and validated the SALFLAGE prognostic score. We analyzed 1079 adults with R/R AML treated across 112 PETHEMA institutions over 26 years (1998–2024), including patients with primary ...
Gaspar Aspas Requena, Rebeca Rodríguez‐Veiga, Cristina Gil, Carmen Botella, Eliana Aguiar, Fernanda Trigo, Mercedes Colorado, Teresa del Bernal del Castillo, Eva Barragan, Mar Tormo, Eduardo Rodríguez Arbolí, Josefina Serrano López, Raimundo García Boyero, Tamara Castaño, Pilar Herrera Puente, Mónica A. Romero Riquelme, María J. Sayas Lloris, Lorenzo Algarra‐Algarra, Carlos Rodriguez‐Medina, Claudia L. Sossa Melo, Jorge Labrador Gomez, Susana Vives, Olga Salamero, María Luz Amigo, Marta Valero Nuñez, Christine Rojas, Francisca Bass, María García‐Fortes, Belén Vidriales Vicente, Marta Polo, Celina Benavente, María D. Madrigal, Marcela Espinoza, Manuel Pérez‐Encinas, María L. Amador Barciela, Guiomar Bautista, Antonio Solana‐Altabella, Isabel Cano‐Ferri, Rafael Colmenares, Patricia García‐Ramírez, Francisco Ibáñez Alis, Manuel Barrios García, Gabriela Rodríguez‐Macías, Miguel López, Ana Yurena Oliva Hernández, Carlos Javier Cerveró, David Martínez‐Cuadrón, Pedro Chorão, Juan M. Bergua Burgues, Pau Montesinos   +49 more
wiley   +1 more source

Biographical Feature: Richard B. (Tom) Thomson, Jr., Ph.D., D(ABMM), F(AAM) [PDF]

, 2018
Munson, Erik
core   +1 more source